Telomir Pharmaceuticals OverviewTelomir Pharmaceuticals Net Income
Profitability analysis for TELO.
Quarterly Net Income
-$990947.00
↑ 54.54% YoY
As of Mar 2026
Annual Net Income (TTM)
-$9.22M
↑ 26.31% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...